The proposed combination envisages acquisition of stake in Ecom Express Private Limited by PG Esmeralda Pte. Limited (PG Esmeralda).
Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.
The Phase 2 study of Sputnik V was conducted on 100 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
The total scope of the investment is intended to support approximately 20 kilotons of LCP production per year with the first phase of the project expected to come on-line in 2024.
This transaction is consistent with Azelis’ corporate strategy of complementing organic growth with strategic acquisitions.
LANXESS will significantly expand its range of products for the growth market animal hygiene
The closing of the transaction, consistent with Azelis’ corporate strategy of complementing organic growth with strategic acquisitions, is expected in the next three months.
The event had no significant impact on other production facilities.
The plant has been temporarily shut-down for maintenance work from today, 11th January 2021.
The production plant as well as the research facilities in Bitterfeld, Germany, including all employees were transferred to SUEZ.
Production Linked Incentives (PLI) is a good measure as it incentivises the industry to quickly put up investment and start commercialise sales.
Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.
Operations at the facilities of the company have at all times been carried out in compliance with the applicable laws
The commercial production of the plant has commenced on 8th January 2021.
The DGTR excluded Japan from the provision
The sharp increase in global crop prices to record highs and healthy agri product demand are likely to boost exports for our CPC universe.
The company has reported total income of Rs.47.50 crores during the 9 months period ended December 31, 2020.
During November, global capacity rose 0.1% and was up 2.2% Y/Y.
Debt reduced to Rs 364 crore as on November 30, 2020 driven by improved working capital management.
The acquisition will boost Jindal Films’ know-how, capabilities, and presence in the pharma, medical and other high end flexible packaging segments.
Subscribe To Our Newsletter & Stay Updated
